Sensei Biotherapeutics (SNSE) director receives stock options on 12,500 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sensei Biotherapeutics director Phillip B. Donenberg received a stock option grant covering 12,500 shares of common stock. The option has an exercise price of $11.41 per share and expires on June 9, 2036.
The award vests in 12 equal monthly installments over one year, so it becomes fully vested on June 10, 2027, as long as Donenberg continues to provide service to the company on each vesting date. After this grant, he holds options for 12,500 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Donenberg Phillip B.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 12,500 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 12,500 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 12,500 shares
Exercise price: $11.41/share
Expiration date: June 9, 2036
+2 more
5 metrics
Option grant size
12,500 shares
Underlying common stock for new stock option award
Exercise price
$11.41/share
Stock option strike price
Expiration date
June 9, 2036
Option term end date
Vesting schedule length
12 months
Monthly vesting until fully vested June 10, 2027
Post‑grant option holdings
12,500 options
Total derivative securities held directly after transaction
Key Terms
Stock Option (right to buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 11.4100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to the option vest and become exercisable in 12 equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-09T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
What did Sensei Biotherapeutics (SNSE) director Phillip Donenberg report on this Form 4?
Phillip B. Donenberg reported receiving a stock option grant for 12,500 shares of Sensei Biotherapeutics common stock. The option was awarded as compensation, rather than bought in the open market, and gives him the right to purchase shares at a set price in the future.
What are the key terms of the SNSE stock options granted to Phillip Donenberg?
The stock option covers 12,500 underlying shares with an exercise price of $11.41 per share and an expiration date of June 9, 2036. These terms define how many shares he can buy, at what price, and for how long the option remains exercisable.
How do the SNSE options granted to Phillip Donenberg vest over time?
The options vest in 12 equal monthly installments over one year, becoming fully vested on June 10, 2027. Each monthly vesting requires Donenberg to remain in continuous service with Sensei Biotherapeutics, aligning the award with ongoing board or service commitments.
How many Sensei Biotherapeutics derivative securities does Phillip Donenberg hold after this grant?
After the transaction, Donenberg holds stock options for 12,500 underlying shares directly. This Form 4 shows only this option position, indicating his reported derivative holdings now match the size of the newly granted award at the disclosed terms.